Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)
| Descriptor ID |
D020277
|
| MeSH Number(s) |
C10.114.750.175 C10.314.750.700 C10.668.829.800.750.600 C20.111.258.750.800
|
| Concept/Terms |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- CIDP
- Polyneuropathy, Inflammatory Demyelinating, Chronic
- Inflammatory Polyradiculopathy, Chronic
- Chronic Inflammatory Polyradiculopathies
- Chronic Inflammatory Polyradiculopathy
- Inflammatory Polyradiculopathies, Chronic
- Polyradiculopathies, Chronic Inflammatory
- Polyradiculopathy, Chronic Inflammatory
- Polyradiculoneuropathy, Chronic Inflammatory
- Chronic Inflammatory Polyradiculoneuropathy
- Chronic Inflammatory Polyradiculoneuropathies
- Polyradiculoneuropathies, Chronic Inflammatory
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
|
Below are MeSH descriptors whose meaning is more general than "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating".
Below are MeSH descriptors whose meaning is more specific than "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating".
This graph shows the total number of publications written about "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" by people in this website by year, and whether "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 4 | 0 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" by people in Profiles.
-
Dalakas MC, Latov N, Kuitwaard K. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations. Expert Rev Neurother. 2022 Nov-Dec; 22(11-12):953-962.
-
Vanhoutte EK, Latov N, Deng C, Hanna K, Hughes RA, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. Eur J Neurol. 2013 May; 20(5):748-55.
-
Dalakas MC. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies. J Peripher Nerv Syst. 2012 May; 17 Suppl 2:34-9.
-
Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 2011 Sep; 7(9):507-17.
-
Deng C, Hanna K, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. J Neurol. 2012 Feb; 259(2):348-52.
-
Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV. Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece. J Peripher Nerv Syst. 2011 Jun; 16 Suppl 1:1-2.
-
Dalakas MC. Potential biomarkers for monitoring therapeutic response in patients with CIDP. J Peripher Nerv Syst. 2011 Jun; 16 Suppl 1:63-7.
-
Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Katzberg H, Latov N, Merkies IS, Van Doorn PA. Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve. 2010 Oct; 42(4):492-7.
-
Donofrio PD, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes R, Latov N, Merkies I, van Doorn P. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2010 Sep; 67(9):1082-8.
-
Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst. 2010 Sep; 15(3):208-15.